Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma

National Medical Journal of China

Volumn 88, Issue 36, 2008, Pages 2529-2532

  Gao, Heng Jun ^a   Liang, Hui Hong ^a   Chen, Min Shan ^a   Peng, Zhen Wei ^a   Zhang, Yao Jun ^a   Li, Peng ^a   Pang, Xiong Hao ^a   Zhang, Ya Qi ^a   Li, Jin Qin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Carcinoma, hepatocellular; Radio frequency ablation; Radiography, interventional; Treatment outcome

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER SIZE; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER NECROSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PATIENT SATISFACTION; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RISK FACTOR; SHORT COURSE THERAPY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 56849085214     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg, 2006, 243: 321-328.
2. Chinese source.
3. Chinese source.
4. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology, 2008, 47:82-89.
5. Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation multivariate meta-analysis and review of contributing factors. Ann Surg,2005,242:158-171.
6. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound, 2001,13: 159-166.
7. Chinese source.
8. Chinese source.
9. Bloomston M, Binitie O, Fraiji E, et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg,2002,68: 827-831.
10. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology, 2005, 234:961-967.
11. Gasparini D, Sponza M, Marzio A, et al. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol Med (Torino), 2002,104:412-420.
12. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 2006,16:661-669.